Biological Material Analysis TRIZ Cases

Amyloid fibers on an electrode detect heavy metal ions through redox current changes.

Engineered allogeneic tumor-infiltrating lymphocytes express membrane-bound interleukin 15 to expand without exogenous cytokines.

A normal incident guided-mode-resonance biosensor detects procalcitonin using optical resonance shifts on a bio-sensing chip.

Modified VRC01 antibodies stabilize interactions with HIV-1 Env trimers through specific amino acid substitutions in the heavy chain variable region framework 3.

High-affinity monoclonal antibodies detect BoNT/B at low concentrations, resolving the trade-off between assay sensitivity and sample preparation complexity.

Simoa-based urine assays detect Mycobacterium tuberculosis antigens to resolve sensitivity and specificity trade-offs in active infection diagnosis.

Stacked analyte detection membranes with pressure actuators enable rapid pathogen identification, reducing analysis time from days to minutes.

Regenerating probes with denaturing reagents reduces cost per test while maintaining clinical assay performance.

In vitro FcRn cell assays measure transcytosis and recycling rates of therapeutic antibodies, replacing costly animal studies with accurate human-relevant data.

A multilayer microfluidic device uses ELISA principles to detect SARS-CoV-2 biomarkers in under 10 minutes.

Engineered CD47 monoclonal antibodies bind human CD47 to block SIRPα interaction, promoting macrophage phagocytosis without red blood cell depletion.

Ion channel markers identify high-risk DCIS lesions to eliminate unnecessary aggressive treatment for low-risk patients.

Monoclonal antibodies targeting death receptor 5 reduce CX3CL1 levels, resolving specificity issues in cancer and arthritis therapies.

A monoclonal antibody recognizes the integrin binding site on human TGF-β LAP degradate for specific immunological detection.

An aptamer sequence achieves sub-100 nM binding to GDF8 while avoiding cross-reactivity with homologous GDF11 proteins.

Segmenting detection via local quality resolves cross-reaction trade-offs, enabling precise malignant B-cell neoplasia diagnosis.

Engineered monoclonal antibody 5F11 achieves picomolar binding affinity to overcome insufficient specificity of current anti-Axl antibodies.

In silico maturation and bivalent linking resolve insufficient binding affinity, enabling highly sensitive VEGF detection without complex antibody production.

A two-stage blood test measures FGF19 levels followed by cholestyramine suppression to validate cancerous origins.

Compartment-specific Ca2+ sensors use tuned affinity variants to measure intracellular concentrations without perturbing the cellular environment.

Directed evolution expands substrate specificity to LMVGG motifs, enabling site-specific protein modification without genetic manipulation.

A progesterone measuring kit uses labeled and unlabeled particles to detect target concentrations.

Functionalized graphene layer measures electrical conductance changes when antibodies bind to viral particles.

CuAAC reactions attach fluorescent probes to azido-modified sugars, resolving glycan heterogeneity challenges for precise intracellular imaging.

A fully human monoclonal antibody R66 binds the respiratory syncytial virus antigen F with high affinity.

Chimeric monoclonal antibodies bind CD44v6 and CD44v9 epitopes with high affinity.

A dual-test-line pregnancy diagnostic device detects beta-core fragment hCG alongside intact hCG for reliable results.

Alkaline conversion of chitin to soluble chitosan enables wheat germ agglutinin binding, resolving insolubility barriers in environmental dust analysis.

Nanoparticle aggregation replaces enzyme-based assays to eliminate reference plasma requirements and reduce measurement errors in blood samples.

Light scattering detects complement factor H concentrations rapidly, bypassing the long incubation times of ELISA and RIA assays.

Targeting early NS1 antigen presence allows diagnosis before antibody production, bypassing equipment needs for field use.

A surface plasmon resonance method immobilizes monomeric FcRn on a solid surface to measure antibody binding kinetics.

Patsnap Eureka TRIZ analysis shows antibodies targeting conserved spike regions maintain efficacy against viral variants while reducing clinical trial delays.

Handheld glucose meter measures ambient temperature and humidity to adjust test magazine validity windows.

A neoantigen selection method evaluates CD4 and CD8 T cell recognition alongside MHC redundancy to identify efficacious immune-stimulating antigens.

GB235-019 reverses Herceptin-induced resistance by blocking redundant growth factor signaling pathways in HER2-positive tumors.

Fully human antibodies bind FcRL5 domains 7 through 9 via phage display screening.

Grooved microchannels generate helical flows to direct suspended particles toward adherent walls.

Removing N-glycosylation motifs from CDR-H2 regions eliminates glycosylation-related immunogenicity while maintaining therapeutic efficacy.

Monoclonal antibodies replace HPLC-MS systems to measure trans-Resveratrol without expensive equipment.

Anti-CD38 single-domain antibodies bind CD38 without triggering internalization, preserving surface antigen expression for reliable therapeutic targeting.

Babesia antigen peptides immobilized on solid supports enable colorimetric detection of parasites in blood samples using standard microplate readers.

Anti-CGRP antibodies improve insulin sensitivity and preserve beta cells to address insulin resistance.

An electrochemically active biosensor uses a receptor layer to bind albumin complexes for quantitative measurement in reduced biological sample volumes.

Lyophilized internal standards with chaotropic agents prevent degradation, ensuring accurate quantification in proteomics workflows.

Bifidobacterium lactis BL-04 modulates immune biomarkers to inhibit viral replication, reducing asthma and COPD exacerbation risks.

A handheld breath analyzer uses AI-driven sensor arrays to detect volatile organic compounds in exhaled air.